Outlook Therapeutics Q3 2024 Earnings Preview
OTLK Stock | USD 1.32 0.08 5.71% |
About 61% of OUTLOOK THERAPEUTICS's investor base is looking to short. The analysis of the overall investor sentiment regarding OUTLOOK THERAPEUTICS INC suggests that many traders are alarmed. OUTLOOK THERAPEUTICS's investing sentiment shows overall attitude of investors towards OUTLOOK THERAPEUTICS INC.
OUTLOOK |
Outlook Therapeutics is set to report Q3 earnings on August 13, with consensus estimates at -0.84 EPS and 0M revenue.
Read at seekingalpha.com
![]() |
OUTLOOK THERAPEUTICS Fundamental Analysis
We analyze OUTLOOK THERAPEUTICS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OUTLOOK THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OUTLOOK THERAPEUTICS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
OUTLOOK THERAPEUTICS is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
OUTLOOK THERAPEUTICS INC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OUTLOOK THERAPEUTICS stock to make a market-neutral strategy. Peer analysis of OUTLOOK THERAPEUTICS could also be used in its relative valuation, which is a method of valuing OUTLOOK THERAPEUTICS by comparing valuation metrics with similar companies.
Peers
OUTLOOK THERAPEUTICS Related Equities
PLX | Protalix Biotherapeutics | 4.03 | ||||
CDTX | Cidara Therapeutics | 3.75 | ||||
FBIOP | Fortress Biotech | 0.47 | ||||
CKPT | Checkpoint Therapeutics | 0.25 | ||||
EYPT | Eyepoint Pharmaceuticals | 1.35 | ||||
DAWN | Day One | 1.47 | ||||
HOOK | Hookipa Pharma | 1.67 | ||||
HRTX | Heron Therapeuti | 2.16 | ||||
SLS | Sellas Life | 4.31 | ||||
KOD | Kodiak Sciences | 4.90 | ||||
MBIO | Mustang Bio | 6.34 | ||||
TERN | Terns Pharmaceuticals | 6.41 | ||||
FBIO | Fortress Biotech | 6.94 | ||||
INZY | Inozyme Pharma | 7.07 | ||||
RVPH | Reviva Pharmaceuticals | 7.34 | ||||
XFOR | X4 Pharmaceuticals | 7.41 | ||||
EYEN | Eyenovia | 10.32 |
Check out OUTLOOK THERAPEUTICS Hype Analysis, OUTLOOK THERAPEUTICS Correlation and OUTLOOK THERAPEUTICS Performance. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.